Dr. Grieselhuber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-366-1164Fax+1 614-293-7484
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
- Ohio State University HospitalResidency, Internal Medicine, 2012 - 2015
- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
- OH State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 15 citationsPP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in Acute Myeloid Leukemia.Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik
Blood. 2021-11-17 - 39 citationsSelective targeting of NAMPT by KPT-9274 in acute myeloid leukemiaShaneice Mitchell, Karilyn Larkin, Nicole Grieselhuber, Tzung Huei Lai, Matthew Cannon
Blood Advances. 2019-02-12 - 117 citationsHigh throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samplesJacqueline E. Payton, Nicole R. Grieselhuber, Li-Wei Chang, Mark Murakami, Gary K. Geiss
The Journal of Clinical Investigation. 2009-06-01
Abstracts/Posters
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationNicole Grieselhuber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Follo...Nicole Grieselhuber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- How Targeted Drugs Can Vanquish a Virulent LeukemiaSeptember 29th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: